APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Apnimed, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 8, 2026
$16.59−1.17 (-6.56%)
Close on Oct 19, 2026
- Market cap
- $536.90M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Apnimed from other investors
No posts about APMD yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.